U.S.: COVID-19 Vaccines – Announcements/Regulatory Actions/Deployment

Milestones :: Perspectives :: Research

 

U.S.: COVID-19 Vaccines – Announcements/Regulatory Actions/Deployment

 

::::::

Vaccines and Related Biological Products Advisory Committee– FDA
https://www.fda.gov/advisory-committees/blood-vaccines-and-other-biologics/vaccines-and-related-biological-products-advisory-committee

Vaccines and Related Biological Products Advisory Committee October 14-15, 2021 Meeting Announcement
Agenda
…Under Topic 1, the committee will meet in open session to discuss the Emergency Use Authorization (EUA) of the ModernaTX Inc. COVID-19 vaccine for the administration of an additional dose, or “booster” dose, following completion of the primary series, to individuals 18 years of age and older. On October 15, 2021, under Topic II, the committee will meet in open session to discuss the Emergency Use Authorization (EUA) of the Janssen Biotech Inc. COVID-19 vaccine for the administration of an additional dose, or “booster” dose, to individuals 18 years of age and older.

Vaccines and Related Biological Products Advisory Committee October 26, 2021 Meeting Announcement – 10/26/2021 – 10/26/2021
Agenda
…The committee will meet in open session to discuss Pfizer Inc.’s request to amend its Emergency Use Authorization (EUA) to allow for the use of the Pfizer-BioNTech COVID-19 vaccine in children 5 through 11 years of age.

 

::::::

White House [U.S.]
Briefing Room – Selected Major COVID Announcements
Remarks by President Biden on the Importance of COVID-⁠19 Vaccine Requirements
October 07, 2021 • Speeches and Remarks

Press Briefing by White House COVID-⁠19 Response Team and Public Health Officials
October 06, 2021 • Press Briefings

Statement by President Joe Biden on Dr. Francis Collins Stepping Down as Director of the National Institutes of Health
October 05, 2021 • Statements and Releases

Statement by President Joe Biden on 700,000 American Deaths from COVID-⁠19
October 02, 2021 • Statements and Releases